High-Frequency Neuronavigated rTMS in Auditory Verbal Hallucinations: A Pilot Double-Blind Controlled Study in Patients With Schizophrenia
Affiliation auteurs | !!!! Error affiliation !!!! |
Titre | High-Frequency Neuronavigated rTMS in Auditory Verbal Hallucinations: A Pilot Double-Blind Controlled Study in Patients With Schizophrenia |
Type de publication | Journal Article |
Year of Publication | 2018 |
Auteurs | Dollfus S, Jaafari N, Guillin O, Trojak B, Plaze M, Saba G, Nauczyciel C, Larmurier AMontagne, Chastan N, Meille V, Krebs M-O, Ayache SS, Lefaucheur JPascal, Razafimandimby A, Leroux E, Morello R, Batail JMarie, Brazo P, Lafay N, Wassouf I, Harika-Germaneau G, Guillevin R, Guillevin C, Gerardin E, Rotharmel M, Crepon B, Gaillard R, Delmas C, Fouldrin G, Laurent G, Nathou C, Etard O |
Journal | SCHIZOPHRENIA BULLETIN |
Volume | 44 |
Pagination | 505-514 |
Date Published | MAY |
Type of Article | Article |
ISSN | 0586-7614 |
Mots-clés | 20 Hz, Auditory Hallucinations Rating Scale, magnetic resonance imaging, Neuronavigation, Placebo, Transcranial magnetic stimulation, Trial |
Résumé | Introduction: Despite extensive testing, the efficacy of low-frequency (1 Hz) repetitive transcranial magnetic stimulation (rTMS) of temporo-parietal targets for the treatment of auditory verbal hallucinations (AVH) in patients with schizophrenia is still controversial, but promising results have been reported with both high-frequency and neuronavigated rTMS. Here, we report a double-blind sham-controlled study to assess the efficacy of high-frequency (20 Hz) rTMS applied over a precise anatomical site in the left temporal region using neuronavigation. Methods: Fifty-nine of 74 randomized patients with schizophrenia or schizoaffective disorders (DSM-IV R) were treated with rTMS or sham treatment and fully evaluated over 4 weeks. The rTMS target was determined by morphological MRI at the crossing between the projection of the ascending branch of the left lateral sulcus and the superior temporal sulcus (STS). Results: The primary outcome was response to treatment, defined as a 30% decrease of the Auditory Hallucinations Rating Scale (AHRS) frequency item, observed at 2 successive evaluations. While there was no difference in primary outcome between the treatment groups, the percentages of patients showing a decrease of more than 30% of AHRS score (secondary outcome) did differ between the active (34.6%) and sham groups (9.1%) (P = .016) at day 14. Discussion: This controlled study reports negative results on the primary outcome but demonstrates a transient effect of 20 Hz rTMS guided by neuronavigation and targeted on an accurate anatomical site for the treatment of AVHs in schizophrenia patients. |
DOI | 10.1093/schbul/sbx127 |